News

Cath Lab Clinical Trial Study Cardiovascular Surgery

National Institutes of Health researchers have identified a biological pathway that contributes to the high rate of vein graft failure following ...

On-X Life Technologies On-X Plus 1.5 Aortic Heart Valve Repair Cardiovascular

On-X Life Technologies Inc.  received CE marking for an expanded labeling claim of its On-X Prosthetic Heart Valve. The company may market its ...

Edwards Lifesciences Embol-X Glide Protection System Embolic Device Surgery

The U.S. Food and Drug Administration (FDA) issued a Class I Recall of Edwards Lifesciences LLC’s Embol-X Glide ...

Heart transplant patients may live 20 years or more after surgery, according to a ...

Gecko Biomedical cardiovascular surgery structural heart adhesive

In a preclinical study, researchers from Boston Children's Hospital, BWH and Massachusetts Institute of Technology (MIT) developed a bio-inspired adhesive that could rapidly attach biodegradable...

duke manmade vein graft venous therapies cardiovascular surgery

An investigational, manmade blood vessel used in vascular grafts for kidney dialysis patients may potentially...

heart valve repair clinical trial study cardiovascular surgery mitral

The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn...

After cardiac surgery, healthcare-associated infections (HAIs) are common complications associated with increased morbidity, mortality, and use of resources.

hybrid approach to treating coronary artery disease that involves a hybrid procedure combining a minimally...

cath lab cardiovascular surgery clinical trial/study scai heart attack

The Society for Cardiovascular Angiography and Interventions (SCAI) assembled  a panel that has proposed new criteria for identifying patients who experience a heart attack after coronary...

Emergency surgery and advanced cardiac disease are risk factors for major adverse cardiac events (MACE) after noncardiac surgery in patients with recent coronary stent ...

Medstreaming launched its new Graphic Based Surgical Application for desktop and mobile platforms at the Vascular Annual Meeting (VAM) May 30 – June 1, 2013 in San Francisco. The structured...

June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has developed a unique mechanical occlusion device called the TigerPaw System II....

Although not designed for cardiovascular surgery, a new robotic surgical system being developed will likely add to the growing interest of using magnetic resonance imaging (MRI...

The FREEDOM trial, the first long-term, comparative study of its kind exclusively for patients with diabetes and advanced multivessel coronary artery disease (CAD) revealed that diabetics with CAD...

bundled payments, cardiology, CMS

The Centers for Medicare and Medicaid Services (CMS) announced that more than 500 organizations will begin participating in the Bundled Payments for Care Improvement initiative. Through this new...

 The U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the HeartWare Ventricular Assist System (VAS) designed as a bridge to cardiac transplantation.

FDA Intra-Aortic Balloon Pumps

November 8, 2012 — A U.S. Food and Drug Administration (FDA) advisory committee is meeting Dec. 5 to discuss how to classify and regulate...

November 7, 2012 — Athera Biotechnologies AB announced that results from a new study were presented at the Pacific Northwest Vascular Society Annual Meeting in Vancouver, Canada. The data shows...

Terumo VirtuoSaph Plus Endoscopic Vessel Harvesting System

Terumo Cardiovascular Systems has announced the introduction of the VirtuoSaph Plus Endoscopic Vessel Harvesting System following clearance by the U.S. Food and Drug Administration (FDA).